Skip to main content

Table 3 Percentage and odds ratios (CI 95%) for metabolic syndrome (MetS) components and cardiovascular risk (CVR) in euthyroid post-menopausal women grouped considering the presence of MetS and triiodothyronine (T3) concentration

From: Association between the serum concentration of triiodothyronine with components of metabolic syndrome, cardiovascular risk, and diet in euthyroid post-menopausal women without and with metabolic syndrome

  Without MetS n=33 MetS-T3Q1 n=22 MetS-T3Q2 n=21 MetS-T3Q3 n=21 MetS-T3Q4 n=23
Waist circumference 30.3% 45.5% 66.7% 85.7% 82.6%
REF 2.8 (0.8-9.7) 6.4 (1.7-23.5)** 16.2 (3.6-72.8)*** 12.7 (3.0-53.3)***
Arterial tension 30.3% 72.7% 81.0% 61.9% 69.5%
REF 5.7 (1.6-19.2)** 10.0 (2.6-38.6)*** 4.1 (1.2-13.3)* 6.2 (1.8-21.0)**
Hyperglycemia 27.3% 95.5% 85.7% 66.7% 65.2%
REF 53.8 (6.2-462.2)*** 15.8 (3.7-67.4)*** 5.4 (1.6-18.1)** 5.2 (1.6-16.9)**
Triglycerides 24.2% 72.7% 52.4% 57.1% 65.2%
REF 8.0 (2.3-27.8)** 3.3 (1.0-10.9)* 4.2 (1.3-13.7)* 6.0 (1.8-19.6)**
Low HDL-C 54.5% 76.2%(21) 76.2% 95.2% 85.7% (21)
REF 2.8 (0.8-9.5) 2.7 (0.8-9.2) 16.4 (1.9-137.6)* 4.9 (1.2-20.0)*
HOMA-IR 24.2% 36.3% 66.7% 66.7% 78.2%
REF 2.4 (0.6-8.5) 8.3 (2.2-30.5)*** 6.8 (1.9-24.2)** 12.3 (3.2-47.1)***
CVR moderate/high 6.1% 45.5%(21) 52.4% 47.6% 19.0%(21)
REF 14.6 (2.7-78.6)*** 17.4 (3.2-92.9)*** 14.0 (2.6-74.3)** 3.5 (0.5-21.7)
  1. Binomial logistic regression was applied adjusting age was for all cases. HDL-C, HDL cholesterol; HOMA-IR, insulin resistance. *P ≤ 0.05, **P < 0.01, and ***P < 0.001. Note: HDL-C was not possible to be measure for all women. Numbers into superscript parenthesis together to prevalence for groups MetS-T3Q1 and MetS-T3Q4 indicate the number of participants for HDL-C and CVR.